In a world where employees and consumers want businesses to be more sustainable, there’s a growing need for business leaders who share these values — and a new type of business education.
Two business professors spent five years studying Walmart’s ambition project to bring sustainability to its millions of budget-conscious customers – a plan that began with the birth of a granddaughter.
Apple became the world’s ‘biggest’ company because of its sky-high valuation. But in the past, the largest companies were known for more meaningful metrics such as revenue and number of employes.
United’s CEO called the Trump policy ‘in deep conflict’ with his company’s values, the latest example of a corporate leader speaking out on a political issue, something almost unheard of a few decades ago.
Canada’s bricks-and-mortar grocery stores are in trouble due to stagnant food prices and changing consumer preferences. More grocery store closures are likely on the horizon.
Facing stiff competition, the obvious solution is for Sainsbury’s and Asda to grow their customer base and revenues, while cutting their margins, through a merger.
Although over 200 CEOs have promised to share windfalls from the recent tax cut with their employers – something the president is likely to bring up in the State of the Union – research suggests workers aren’t holding their breath.
CEOs used to stay steadfastly neutral on divisive social and political issues. Those days are over, meaning today’s chief executive increasingly resembles Che Guevera.
The deal escaped scrutiny because the two aren’t direct competitors, yet Amazon’s huge marketing platform will help Whole Foods steamroll rivals. In the past, the Supreme Court has said this violates antitrust law.
Companies, which in the past tended to stay neutral on divisive social and political issues, are increasingly taking a stand. What’s behind the change?
The food on our tables is central to the #COP21 debate and any Paris agreement must help build a system that moves us a long way from our current habits.
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California